Clark Wealth Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Clark Wealth Partners's WST Position: Q3 2026 in Review
Clark Wealth Partners held its West Pharmaceutical (WST) position steady in Q3 2026 at 4 shares worth $1.48K. The position accounts for ﹤0.01% of the portfolio, ranked #718.
Clark Wealth Partners first reported a position in WST in Q4 2024 and has held it in 5 quarters since. The position peaked at $3.5K in Q2 2025. 865 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Clark Wealth Partners held 4 shares of West Pharmaceutical worth $1.48K as of Q3 2026.
- Clark Wealth Partners left its West Pharmaceutical share count unchanged in Q3 2026.
- West Pharmaceutical made up ﹤0.01% of Clark Wealth Partners's portfolio in Q3 2026, its #718 holding.
- Clark Wealth Partners first reported a position in West Pharmaceutical in Q4 2024 and has held it in 5 quarters since.
- Clark Wealth Partners's West Pharmaceutical position peaked at $3.5K in Q2 2025.
- 865 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Clark Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.